Duodart

Not a healthcare professional? Visit our Public site

For Healthcare Professionals

Not a healthcare professional? Visit our Public site

This site May contain promotional material

1

Basket

User logged in

Report adverse event

Menu

Close

For Healthcare Professionals

May contain promotional material

Visit our Public site

Popup

ASYEVE0001=Event Registration-Portal
ASYEVE0002=Watched General Video
ASYEVE0003=Watched Virtual Rep Video
ASYEVE0004=Watched Patient Video
ASYEVE0005=Watched Expert Video
ASYEVE0006=Watched Webcast
ASYEVE0007=Downloaded Content-Portal
ASYEVE0008=Clicked to App Store
ASYEVE0009=Watched Learning Module Video
ASYEVE0010=eMail Sent
ASYEVE0011=eMail Read
ASYEVE0012=eMail Clicked
ASYEVE0013=Shared a Link
ASYEVE0014=Rep Request
ASYEVE0015=Joined health.gsk
ASYEVE0016=email Not Sent
ASYEVE0017=Email Not Sent
ASYEVE0018=Email Not Sent
ASYEVE0037=IJSFAID is not available
ASYEVE0038=EMAIL ID and IJSFAID is not available
ASYEVE0039=The user is opted out
ASYEVE0040=Scope IDs are different

Account activated – pending validation.

Your account has been activated successfully, but we still need to validate you as a healthcare professional. We’ll send you an email with the result of the validation process in the next three days.

In the meantime, you can enjoy access to all the latest news, events and resources for different therapy areas on our website.

Event registration completed - pending validation.

Your account has been activated successfully, but we still need to validate you as a healthcare professional. We’ll send you an email with the result of the validation process in the next three days.

In the meantime, you can enjoy access to all the latest news, events and resources for different therapy areas on our website.

Account activated - pending validation.

Your account has been activated successfully, but we still need to validate you as a healthcare professional. We’ll send you an email with the result of the validation process in the next three days.

In the meantime, you can enjoy access to all the latest news, events and resources for different therapy areas on our website.

Event Account activated - pending validation.

Your account has been activated successfully, but we still need to validate you as a healthcare professional. We’ll send you an email with the result of the validation process in the next [five] days.

In the meantime, you can enjoy the public content on our website

In case you would like to receive sms-reminders for the event you have registered, please update your communication preferences here.

already registered

X »

You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

Duodart

Composition 1

Each hard capsule contains 0.5 mg dutasteride and 0.4 mg tamsulosin hydrochloride, (equivalent to 0.367 mg tamsulosin).

Dutasteride:

Tamsulosin hydrochloride:

Indication 1

Duodart is indicated as combination therapy for the treatment of moderate to severe symptoms of benign prostatic hyperplasia (BPH).

Duodart reduces the risk of acute urinary retention (AUR) and the need for surgery in patients with moderate to severe symptoms of BPH.

Find out more

References:

Duodart Prescribing Information, Version 02.

Duodart Prescribing information

Get in Touch

To discuss our products, supply, educational events or any other information.

Contact us

Gsk.com

For more information, please refer to the prescribing information or contact GlaxoSmithKline via gcc.medinfo@gsk.com.
To report Adverse Event/s associated with the use of GSK product/s, please contact us via gulf.safety@gsk.com.
All Quality complaints should be reported to the LOC Quality department mail box Gulf.ProductQualityComplaints@gsk.com.

Sorry, this site is not supported on Android v4.3 and below.

Please update your operating system or use a different device.

Benign Prostatic Hyperplasia (BPH)

You are now leaving GSK’s website

Duodart

Dutasteride:

Tamsulosin hydrochloride:

Find out more

References:

Contact us

Sorry, this site is not supported on Android v4.3 and below.